{
  "url": "https://openlegislation.uk/human-medicines-regulations-2012/regulation-242",
  "json_url": "https://openlegislation.uk/human-medicines-regulations-2012/regulation-242.json",
  "legislation": "uksi/2012/1916",
  "legislation_title": "The Human Medicines Regulations 2012",
  "legislation_url": "https://openlegislation.uk/human-medicines-regulations-2012",
  "path": "regulation/242",
  "kind": "regulation",
  "number": "242",
  "heading": "Exemption for medicinal products at high dilution",
  "text": "(1) Regulations 220 and 221 do not apply to the sale or supply, or offer for sale or supply by a person (“P”) of a medicinal product if—\n(a) the medicinal product is neither for parenteral administration nor a product subject to special medical prescription;\n(b) paragraph (2) applies to the medicinal product; and\n(c) P has been requested by or on behalf of a particular person and in that person's presence to use P's own judgment as to the treatment required.\n(2) This paragraph applies to a medicinal product that consists solely of one or more unit preparations of—\n(a) any substance where the unit preparation has been diluted to at least one part in a million (6x);\n(b) any substance that is listed in Part 1 of Schedule 21 where the unit preparation has been diluted to at least one part in a thousand (3x); or\n(c) any substance that—\n(i) is the active substance of a medicine that is subject to general sale;\n(ii) is listed in Part 3 of Schedule 21; or\n(iii) in the case of a medicinal product for external use only, is listed in Part 4 of Schedule 21,\nwhere the unit preparation has been diluted to at least one part in ten (1x).\n(3) Regulation 220 does not apply to the sale, supply, or offer for sale or supply by a person of a medicinal product if—\n(a) the medicinal product is neither for parenteral administration nor a product subject to special medical prescription;\n(b) paragraph (4) applies to the medicinal product; and\n(c) the conditions in regulation 221 are met.\n(4) This paragraph applies to a medicinal product that consists solely of one or more unit preparations of—\n(a) any substance where the unit preparation has been diluted to at least one part in a million million (6c);\n(b) any substance that is listed in Part 2 of Schedule 21 where the unit preparation has been diluted to at least one part in a million (6x); or\n(c) any substance that—\n(i) is the active substance of a medicine that is subject to general sale;\n(ii) is listed in Part 3 of Schedule 21; or\n(iii) in the case of a medicinal product for external use only, is listed in Part 4 of Schedule 21,\nwhere the unit preparation has been diluted to at least one part in ten (1x).",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Words in reg. 242(1)(a) substituted (E.W.S.) (31.3.2014) by The Human Medicines (Amendment) Regulations 2014 (S.I. 2014/490), regs. 1(2), 5(2)(g) and words in reg. 242(1)(a) substituted (N.I.) (31.3.2014) by The Human Medicines (Amendment) Regulations 2014 (S.R. 2014/323), regs. 1(2), 5(2)(g)"
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Words in reg. 242(3)(a) substituted (E.W.S.) (31.3.2014) by The Human Medicines (Amendment) Regulations 2014 (S.I. 2014/490), regs. 1(2), 5(2)(g) and words in reg. 242(3)(a) substituted (N.I.) (31.3.2014) by The Human Medicines (Amendment) Regulations 2014 (S.R. 2014/323), regs. 1(2), 5(2)(g)"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2012/1916/regulation/242",
    "retrieved_at": "2026-10-29T01:24:34.993203+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}